Pharmaceutical and its use for the treatment of states of agitation and nervous dysfunctions
AssigneeSteigerwald Arzneimittelwerk GmbH
InventorsWerner Schneider, Erich F. Elstner, Elisabeth Kleber
Life of this patent
Estimating the term…
Abstract
The invention concerns a pharmaceutical and its use for the treatment of states of agitation and nervous dysfunctions, which comprises as active ingredients extracts of Corydalis and Eschscholtzia obtained by alcohol extraction (2.5:10), optionally together with conventional additives, the weight ratio of the extract Eschscholtzia to Corydalis being in the range from 20:1 to 1:1.
Claims13
A pharmaceutical composition comprising a combination of an extract of Corydalis and an extract of Escholtzia, wherein both extracts are obtained by alcohol extraction, wherein the ratio of active ingredients in said extracts to said extracts is 2.5:10, wherein the weight ratio of the extract of Escholtzia to the extract of Corydalis in said composition is in the range of from about 20:1 to 1:1, and wherein said composition may additionally contain a pharmaceutically acceptable carrier.
A method for ameliorating or suspending states of agitation and nervous dysfunctions, based on a disturbance of the amine balance, comprising administering to a subject afflicted with said states a pharmaceutically effective amount of a pharmaceutical composition comprising a combination of an extract of Corydalis and an extract of Escholtzia, wherein both extracts are obtained by alcohol extraction, wherein the ratio of active ingredients in said extracts to said extracts is 2.5:10, wherein the weight ratio of the extract of Escholtzia to the extract of Corydalis in said composition is in the range of from about 20:1 to 1:1.
A method for ameliorating or suspending a state of depression, comprising administering to a subject afflicted with depression a pharmaceutically effective amount of a pharmaceutical composition comprising a combination of an extract of Corydalis and an extract of Escholtzia, wherein both extracts are obtained by alcohol extraction, wherein the ratio of active ingredients in said extracts to said extracts is 2.5:10, wherein the weight ratio of the extract of Escholtzia to the extract of Corydalis in said composition is in the range of from about 20:1 to 1:1.
A method for ameliorating the symptoms and side-effects of Parkinson's disease, comprising administering to a subject afflicted with Parkinson's disease a pharmaceutically effective amount of a pharmaceutical composition comprising a combination of an extract of Corydalis and an extract of Escholtzia, wherein both extracts are obtained by alcohol extraction, wherein the ratio of active ingredients in said extracts to said extracts is 2.5:10, wherein the weight ratio of the extract of Escholtzia to the extract of Corydalis in said composition is in the range of from about 20:1 to 1:1.
Dependencies are inferred from the claim text.